We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Catalent, Palatin Technologies Announce Agreement

News   Jul 07, 2016

 
Catalent, Palatin Technologies Announce Agreement
 
 
Advertisement
 

RELATED ARTICLES

Trial Will Investigate if Anti-Nausea Drug Can Alleviate Hallucinations in People With Parkinson's

News

Phase 2 clinical trial will explore if the drug ondansetron is safe and effective against hallucinations in patients with Parkinson's disease.

READ MORE

Investigational Drug Safely Slows Progression of Diabetic Kidney Disease in Clinical Trial

News

Patients with diabetic kidney disease could potentially be treated with an investigational new drug that may slow the progress of their illness without harmful adverse effects to their hearts, according to the results of a recent global clinical trial.

READ MORE

Inhibitor of Cancer-Causing KRAS Gene Mutation Shrinks Tumors and is Well-Tolerated

News

A novel agent that targets a mutated form of the KRAS gene shrank tumors in most patients in a clinical trial with manageable side effects, researchers reported today.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE